The overexpression of SNHG6 has been associated with the progression of tumor and poor prognosis in colorectal cancer [32], gastric cancer [33], prostate cancer [34], HCC [31] lung cancer [35], breast cancer [36], gliomas [37] and many more. This evidence concerns the gene SNHG6 and neoplasm.